Skip to content

Findings
Research is more impactful and relevant when patients and other stakeholders are treated as equal partners throughout the entire study lifecycle.
A lack of shared vision, clear communication protocols, and defined roles are significant barriers to the success of multi-stakeholder research teams.
Engaging diverse stakeholders leads to the development of more patient-centered research questions and outcome measures that reflect real-world priorities.
Institutional barriers, such as inflexible policies on compensation and data access for non-researcher team members, frequently undermine effective collaboration.
Successful patient-centered outcomes research (PCOR) requires specific skills in collaborative problem-solving, conflict navigation, and leading productive team meetings.

Recommendations
Integrate patients, caregivers, clinicians, and other stakeholders into research teams from the initial planning stages to ensure alignment with patient needs.
Establish a shared vision and clear ground rules for communication, decision-making, and responsibilities to foster a cohesive and productive team environment.
Provide training and resources for all team members on best practices for stakeholder engagement, collaborative teamwork, and patient-centered research methods.
Institutions should develop supportive infrastructure, including fair compensation policies and streamlined onboarding processes, to facilitate meaningful stakeholder participation.
Research plans should be flexible, allowing teams to adapt their engagement strategies and methodologies in response to stakeholder feedback and changing circumstances.

Regulatory Considerations
Evidence generated through patient-centered outcomes research can strengthen regulatory submissions by demonstrating that a product’s benefits are meaningful to patients.
The inclusion of diverse patient populations in research, a core tenet of PCOR, helps generate real-world evidence that is more generalizable and relevant for post-market surveillance.
Regulatory bodies are increasingly emphasizing the use of patient-experience data and patient-reported outcomes, which are central to the PCORI research model.
Engaging stakeholders in the selection of clinical trial endpoints helps ensure alignment with patient priorities, which can facilitate more efficient regulatory review.
The collaborative, transparent methods promoted by PCORI can help build trust and align expectations among researchers, patients, and regulatory agencies.